Allison Malkin
Investor Relations
Replay available
Waldencast plc (NASDAQ: WALD) Q4 2024 earnings conference call, held 2025-03-19. Replay captured from the company's public earnings webcast.

Investor Relations
Founder & Chief Executive Officer
Chief Financial Officer
Analyst, Canaccord Genuity
Analyst, TD County
Analyst, Jefferies
Analyst, DA Davidson
Analyst, Raymond James
Analyst
Greetings. Welcome to the WaltonCast fourth quarter and fiscal year 2024 earnings call. This time, all participants are in listen-only mode. The question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero from your telephone keypad. As a reminder, this conference is being recorded. At this time, it's now my pleasure to introduce Allison Malkin with Investor Relations. Thank you, Allison. You may now begin. Thank you and welcome to the WaldenCast PLC fourth quarter and fifth per year 2024 earnings call. Here with me today are Michelle Brissett, founder and chief executive officer, and Manuel Manfredi, chief financial officer. For today's call, Michelle will begin with an update on our business and vision and discuss the company's performance within the context of the beauty market. Manuel will follow with a review of the fourth quarter and full year performance and provide our fiscal 2025 outlook. Following this, Michelle will share the strategic growth initiatives for our milk makeup and Obagi medical brands. After the prepared remarks, the operator will open the call to take questions. I would like to remind you that management will make certain statements today, which are forward-looking in nature, including statements regarding the outlook of WalmanCast business and other matters referenced in the company's earnings relief that was issued yesterday. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those projected in or implied by such statements. Additional information regarding these statements appears under the heading Cautionary Note Regarding Forward-Looking Statements in the company's ear...